These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7451364)

  • 1. PS-6 and PS-7, new beta-lactam antibiotics. In vitro and in vivo evaluation.
    Sakamoto M; Shibamoto N; Iguchi H; Okamura K; Hori S; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1980 Oct; 33(10):1138-45. PubMed ID: 7451364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PS-5, a new beta-lactam antibiotic. II. Antimicrobial activity.
    Sakamoto M; Iguchi H; Okamura K; Hori S; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Apr; 32(4):272-9. PubMed ID: 38238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.
    Kobayashi F; Saino Y; Koshi T; Hattori Y; Nakayama M; Iwasaki A; Mori T; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Apr; 21(4):536-44. PubMed ID: 6979308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boesenbergia rotunda (L.) Mansf. extract potentiates the antibacterial activity of some β-lactams against β-lactam-resistant staphylococci.
    Teethaisong Y; Pimchan T; Srisawat R; Hobbs G; Eumkeb G
    J Glob Antimicrob Resist; 2018 Mar; 12():207-213. PubMed ID: 29102774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
    Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
    Deguchi K; Oda S; Sato Y; Ikeda Y; Nakamura T
    Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms.
    Sakamoto M; Ishikura T; Fukagawa Y
    J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of causative bacteria for bovine mastitis and their susceptibility to beta-lactam antibacterial agents].
    Kamata S; Matsunaga T; Uchida K; Uchida K
    Jpn J Antibiot; 1990 Oct; 43(10):1698-712. PubMed ID: 2086812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inoculum effect of β-lactam antibiotics.
    Lenhard JR; Bulman ZP
    J Antimicrob Chemother; 2019 Oct; 74(10):2825-2843. PubMed ID: 31170287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics.
    Vanhoof R; Gordts B; Coignau H; Stas G; Butzler JP
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():63-6. PubMed ID: 19802970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro antibacterial activity of imipenem compared with four other beta-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospital.
    Santos-Ferreira MO; Vital JO
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():23-6. PubMed ID: 3469195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocardicin A, a new monocyclic beta-lactam antibiotic V. In vivo evaluation.
    Mine Y; Nonoyama S; Kojo H; Fukada S; Nishida M
    J Antibiot (Tokyo); 1977 Nov; 30(11):932-7. PubMed ID: 338567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).
    Ishii Y; Ueda C; Kouyama Y; Tateda K; Yamaguchi K
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):443-8. PubMed ID: 21396543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
    Acred P; Ryan DM; Sowa MA; Watts CM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity.
    Weaver SS; Bodey GP; LeBlanc BM
    Antimicrob Agents Chemother; 1979 Apr; 15(4):518-21. PubMed ID: 380462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antibacterial activity of new oxime type of beta-lactam antibiotics].
    Holá V; Adensamová J; Mandel M
    Cesk Farm; 1990 Sep; 39(7):302-4. PubMed ID: 2098202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
    Clarke AM; Zemcov SJ; Campbell ME
    J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.